Experts Available for Interviews:


To submit an interview request for one of these experts, please contact:

Kelly McCurdy
Vice President, Marketing and Public Relations, HMP Global
610.560.0500 x4304
pr@hmpglobal.com

 


 

Barry T. Katzen, MD, FACC, FACR, FSIR, is the founder and Medical Director of Miami Cardiac & Vascular Institute as well as Voluntary Professor of Radiology at the University of Miami School of Medicine as well as Clinical Professor of Radiology at the University of South Florida College of Medicine.  Most recently Dr. Katzen became Associate Dean for Clinical Affairs at the Florida International University Herbert Wertheim College of Medicine.

Dr. Katzen is considered a pioneer of angioplasty thrombolysis and has a particular interest in treatment of aortic (AAA, TAA) and peripheral aneurysms, peripheral arterial disease (PAD) and critical limb ischemia, carotid artery disease, renal vascular hypertension, and vascular malformations. He has participated in the innovation of new therapies for a number of vascular diseases.

Throughout his medical career, Dr. Katzen has been a leader in the development of new less invasive procedures, and published extensively in the scientific literature. Additionally, he serves on editorial boards for numerous journals, and has been the founding editor of two journals in the field, he is author and co-author of numerous text books as well. Dr. Katzen had an early interest in the use of the Internet for education and physician interaction, and in 1995, along with his partners, founded the Endovascular Forum, one of the first interactive physician websites in the world.
He is a program director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).

Dr. Katzen received his medical degree from the University of Miami School of Medicine. He completed his radiology residency at the New York Hospital-Cornell Medical Center, with fellowship in cardiovascular radiology at St. Vincent’s Hospital Medical Center in New York, as well as the University of Rome, Italy. He later trained in Europe on several occasions, developing a deep understanding of the delivery of healthcare in multinational settings.

 



James F. Benenati, MD, FSIR, is the Medical Director of the Peripheral Vascular Laboratory at the Miami Cardiac & Vascular Institute where he first joined in 1990.  
He is Clinical Associate Professor of Radiology at the University of South Florida College of Medicine and Program Director of the ACGME-accredited fellowship program in interventional radiology at the Institute.

Dr. Benenati has participated in clinical research projects for abdominal aortic aneurysm repair with endografts; stents in peripheral vascular disease; prevention of restenosis in the femoral and popliteal arteries and in carotid stenting trials. He has participated in national trials evaluating uterine embolization for the treatment of symptomatic fibroids and has organized national educational symposia regarding fibroid embolization.

In addition to lecturing internationally, Dr. Benenati has authored and co-authored over 100 scientific article and abstracts that have been published in medical journals including the Journal of the American Medical Association, Radiology, Journal of Vascular & Interventional Radiology and Journal of Vascular Surgery. He has also edited medical textbooks dealing with different aspects of interventional radiology, and is active in educational activities for the SIR.
He is a program director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).

He has held offices in several societies. He is Past President of the Society of Interventional Radiology and served on the Executive Council of the Society of Interventional Radiology in a variety of positions including Annual Meeting Chairman. He is a past president of the Intersociety Commission for the Accreditation of Vascular Laboratories (ICAVL).

Dr. Benenati received his bachelor's degree from the University of Notre Dame and his medical degree from the University of South Florida College of Medicine. He completed a residency in diagnostic radiology at Indiana University Medical Center and a fellowship in cardiovascular and interventional radiology at Johns Hopkins Medical School.

 



Alex Powell, MD, FSIR, is Medical Director of Interventional Radiology at Miami Cardiac & Vascular Institute and has been an interventional radiologist there since 1997. Dr. Powell is Board-certified by the American College of Radiology and has a Certificate of Added Qualification in vascular interventional radiology. He is a member of the Society of Interventional Radiology and the Radiological Society of North America.

Dr. Powell has published numerous articles and book chapters on various aspects of endovascular medicine. He treats all types of peripheral artery disease including critical limb ischemia, vascular malformation and aneurysm repair. He also has a keen interest in interventional oncology as well as non vascular interventional radiology. He has lectured around the world.
He is a program director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).

Dr. Powell received his bachelor's degree from the University of California in Los Angeles and his medical degree from the University of Michigan School of Medicine. He completed a residency in diagnostic radiology at Henry Ford Hospital in Detroit, where he was also chief resident from 1995-1996. Dr. Powell completed a fellowship in interventional radiology at the University of California in San Diego.

 



Ramon Quesada, MD, FACP, FACC, FSCAI, FCCP, is Medical Director of Interventional Cardiology at Baptist Cardiac & Vascular Institute, Baptist Hospital of Miami, and has served as co-director of the Cardiac Catheterization Lab at the Hospital Centro de Diagnostico y Emergencias, San Salvador.

Dr. Quesada, a Fellow of the American College of Cardiology, Society of Cardiac Angiography and Intervention, and the American College of Chest Physicians, earned his medical degree from the University of El Salvador. He completed a residency and fellowships in cardiology and interventional cardiology at University of Miami affiliated hospitals. He is certified by the American Board of Internal Medicine with a specialization in cardiovascular disease, and by the American Board of Interventional Cardiology.

Fluent in English and Spanish, Dr. Quesada practices at Baptist Hospital of Miami and South Miami Hospital.

 



Constantino Peña, MD, is an interventional radiologist at the Miami Cardiac and Vascular Institute where he joined the team in 2005. Dr. Peña is Board-certified in Diagnostic Radiology with a Certificate of Added Qualifications in Vascular and Interventional Radiology. He is a diplomate of the Board of Cardiovascular CT. 

Previously, he was director of interventional radiology at Mercy Hospital in Miami. His experience also includes a staff position in abdominal imaging and intervention at Massachusetts General Hospital. During his years there, he also was a clinical fellow in radiology at Harvard Medical School, and later an instructor of radiology at Harvard Medical School.

He has authored and co-authored many scientific articles and chapters that have been published in medical journals, including the Journal of Vascular and Interventional Radiology, Journal of Vascular Surgery, and American Journal of Radiology. He has also presented numerous lectures and education sessions for doctors on clinical research trials, atherosclerotic occlusive disease, aortic aneurysms, uterine artery embolization, peripheral angiography and vascular imaging.

He is a program director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).

Dr. Peña received his bachelor's and master's degrees from Stanford University, and his medical degree from Yale University School of Medicine. He then completed an internship in internal medicine at Yale-New Haven Hospital and a residency in diagnostic radiology at Massachusetts General Hospital, where he served as chief resident. He then completed his post-graduate training with a fellowship in vascular intervention at Massachusetts General Hospital.

 



Adam Geronemus, MD, is an interventional radiologist at Miami Cardiac & Vascular Institute as well as at the South Miami Heart Center in Miami, Florida and is Board-Certified in Diagnostic Radiology with a Certificate of Added Qualification in vascular and interventional radiology.

Dr. Geronemus has served as adjuvant faculty in the world-renown International Symposium on Endovascular Therapy (ISET). He is an active member of the American Medical Association, the Radiological Society of North America, the American Roentgen Ray Society and the Society of Interventional Radiology.

He is a program director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).

Dr. Geronemus received his undergraduate degree from Indiana University and his medical degree from the University of South Florida College of Medicine in Tampa, Florida. He completed a residency in diagnostic radiology at the University of South Florida College of Medicine, as well as a fellowship in interventional radiology at Miami Cardiac & Vascular Institute.

 



Ripal Gandhi, MD, FSIR, FSVM, is a member of the Miami Cardiac & Vascular Institute physician team and specializes in minimally invasive treatments for peripheral vascular disease, cancer, and other diseases.

Prior to joining Miami Cardiac & Vascular Institute, he was an international visiting scholar at Asan Medical Center/University of Ulsan Medical School in Seoul, South Korea. As an international scholar, he gave several lectures and furthered his expertise in innovative minimally invasive therapies.

Dr. Gandhi is the recipient of multiple awards, including the American College of Physicians Certificate of Merit for Outstanding Performance in Medicine, RSNA resident research award, and scholar award/travel grant from the Society of Interventional Radiology. In addition, he was recently honored with the Patients' Choice Recognition Award, given to physicians most highly regarded by their patients. He is also a fellow of the Society for Vascular Medicine.
He is the co-author of the textbook Interventional Oncology which was recently published.  In addition to being an expert in endovascular therapy and vascular disease, Dr. Gandhi is one of the interventional oncologists at Miami Cancer Institute and has an expertise in minimally invasive therapies for cancer.
He is a program director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).

Dr. Gandhi did his undergraduate studies at Northwestern University and Harvard University. He graduated summa cum laude (highest honors). He received his degree in medicine from Northwestern University Medical School, where he also graduated with honors. Following medical school, he completed a surgical internship at Cornell University Medical Center and New York Presbyterian Hospital. He completed his residency training and fellowship at UCLA Medical Center. Currently, he is an associate clinical professor at the University of South Florida School of Medicine and FIU Herbert Wertheim College of Medicine. Dr. Gandhi regularly trains other physicians in various vascular/endovascular, interventional radiology, and interventional oncology techniques.

 



Kenia Lynn, PA, Miami Cardiac and Vascular Institute

 



Daniel Clair, MD, is Chair of the Department of Surgery for the University of South Carolina (USC) and the Palmetto Health-USC Medical Group, and serves as Senior Medical Director for Surgical Services at Palmetto Health.

Dr. Clair’s clinical interests include carotid artery surgery, thoracic and abdominal aortic aneurysm repair, peripheral artery and vein bypass surgery, and endovascular stent repair. He is board certified in surgery and vascular surgery, and is a distinguished fellow of the Society for Vascular Surgery. His research interests focus on clinical trials of minimally invasive vascular therapies, and he has served as national principal investigator for several large multi-site clinical trials. He has authored or co-authored more than 60 professional articles and book chapters and serves as a member of the editorial board of the Journal of Vascular Surgery and as section editor of Vascular Disease Management.

Dr. Clair received his medical degree from the University of Virginia School of Medicine in Charlottesville followed by an internship, residency and chief residency in surgery at Brigham and Women’s Hospital in Boston. After completing his residency, he pursued a fellowship in clinical oncology from the American Cancer Society, a fellowship in vascular surgery from Brigham and Women’s Hospital in Boston, and a research fellowship as a research scientist at VazoRx Inc., in Woburn, Massachusetts.

 



William Gray, MD, is System Chief, Division of Cardiovascular Disease at Main Line Health and President of the Lankenau Heart Institute in Wynnewood, Pennsylvania.  

Dr. Gray started in private practice in Albuquerque, New Mexico in 1992 to 1999, during which he became a board member and president of a free-standing Heart Hospital.  There he began research in early non-surgical approaches to peripheral vascular disease, especially in patients with carotid artery disease at risk for stroke.

He then went to the Swedish Medical Center in Seattle, Washington to begin a program in Endovascular Care.  While there is also started research into structural heart disease, specifically stroke prevention and non-surgical repair of mitral valve leakage.

Dr. Gray turned to academic medicine at Columbia University in 2005, where he practiced, taught, and conducted clinical research, including designing national clinical trials and studies of devices that ultimately won approval by the FDA. Dr. Gray was an active member of the Cardiovascular Research Foundation, a freestanding non-profit that conducts, analyzes and reports on large-scale research and was co-director of the largest interventional cardiology educational meeting in the world annually.

Dr. Gray graduated cum laude from Dickinson College in 1980, and Temple University School of Medicine in 1984. He competed an internship, residency and chief residency at Brown University from 1984–88. Dr. Gray continued at Brown University until 1992 to complete his clinical cardiology fellowship, which included a year of basic research and a year of dedicated interventional training.

David Chris Metzger, MD, is an Interventional Cardiology and Internal Medicine specialist at Wellmont CVA Heart Institute.  At the Wellmont Holston Valley Medical Center in Kingsport, Tennessee, Dr. Metzger also serves as Director of the Cardiac and Peripheral Vascular Cath Lab and Medical Director of Clinical Research. 
Dr. Metzger also specializes in Interventional Cardiology and Internal Medicine and is affiliated with many hospitals including Clinch Valley Medical Center, Wellmont Lonesome Pine Hospital, Smyth County Community Hospital, Takoma Regional Hospital, Wellmont Holston Valley Medical Center. 

Dr. Metzger graduated from Marshall University Joan C Edwards School of Medicine in 1992 and has decades of diverse experience, especially in Interventional Cardiology. He completed a residency at Wake Forest Baptist Medical Center. 

 



Jihad Mustapha, MD, is an interventional cardiologist and CEO of the Advanced Cardiac and Vascular Amputation Prevention Centers at the Michigan State University College of Osteopathic Medicine in Grand Rapids, Michigan.

Dr. Jihad Mustapha has held many academic and professional titles throughout his career, but the one he’s most proud of is the simplest: “The Leg Saver.”

Dr. Mustapha developed the notion early in his practice that a device to unblock arteries leading to the heart might be used to perform the same thing for legs. Dr. Jihad Mustapha performed his first peripheral vascular limb-salvage treatment more than a dozen years ago, preventing the amputation of the leg of a 52-year-old woman suffering from severe peripheral artery disease, or PAD.
Today, Dr. Jihad Mustapha is recognized throughout the world as a pioneer for his groundbreaking work in critical limb ischemia, or CLI, which is marked by the severe obstruction of arteries drastically reducing blood flow to the extremities. He has authored numerous papers and teaches and speaks internationally on the topic.

Dr. Jihad Mustapha’s story is even more incredible considering that at just 15, he fled his war-torn homeland of Lebanon, landing alongside not a single friend or family member at JFK airport, with $80 to his name and little more than a single change of clothes.

By the next day – despite knowing no English – he was hawking umbrellas and flowers on the streets of New York. He enrolled in night school to learn the language, lived with a sister to save money, and eventually moved to Michigan, where he worked at a restaurant cleaning toilets and bussing tables.

He is proud to have co-founded the first Advanced Cardiac and Vascular Amputation Prevention Center. With nephew Fadi Saab, M.D., Dr. Jihad Mustapha hopes it will serve as a national model for amputation prevention – one of many to eventually take root throughout the United States.

Dr. Mustapha is a Founder and Director of the AMPutation Prevention Symposium, and a Founding Board Member of the CLI Global Society.

Dr. Mustapha graduated from the pre-med program at Wayne State University and earned his medical degree from St. George University School of Medicine in Grenada.

 



Richard Neville, MD, is Director of Inova Vascular, Associate Director of the Inova Heart and Vascular Institute and Vice-Chairman of Surgical Sub-Specialties at Inova Fairfax Medical Campus in Falls Church, Virginia. 

Dr. Neville has consistently been named to the Best Doctors in America and Washingtonian Top Docs. His clinical interests include lower extremity revascularization, wound healing, amputation prevention, carotid artery treatment for stroke prevention, as well as hemodialysis access.

He also served as a professor in the Department of Surgery and as the Ludwig chief of vascular surgery at George Washington University. Prior to that position he was Chief of Vascular Surgery at Georgetown University.

Dr. Neville earned his Bachelor of Science degree from the University of Notre Dame and medical degree at the University of Maryland School of Medicine. Dr. Neville obtained postgraduate training in general surgery at Georgetown University, vascular surgery at University of Medicine and Dentistry of New Jersey – New Jersey Medical School, and endovascular therapy at the National Institutes of Health.